Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 6/20 | 0.69 |
| ▸ | MPO | P05164 | 5/20 | 0.69 |
| ▸ | HTR1D | P28221 | 5/20 | 0.61 |
| ▸ | HTR2A | P28223 | 5/20 | 0.60 |
| ▸ | HTR6 | P50406 | 1/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.57 |
| ▸ | HTR1B | P28222 | 2/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30877219 | 0.93 | HTR2A (0.71) | HTR1AMPOHTR1DHTR2AHTR6 | |
| SCHEMBL24693829 | 0.93 | HTR2A (0.71) | HTR1AMPOHTR1DHTR2AHTR6 | |
| SCHEMBL29206456 | 0.89 | HTR2A (0.63) | HTR1AMPOHTR1DHTR2AGPR84 | |
| SCHEMBL30877226 | 0.89 | HTR2A (0.63) | HTR1AMPOHTR1DHTR2AGPR84 | |
| SCHEMBL24692743 | 0.86 | HTR2A (0.70) | HTR1AMPOHTR1DHTR2AHTR6 | |
| SCHEMBL30483726 | 0.86 | HTR2A (0.70) | HTR1AMPOHTR1DHTR2AHTR6 | |
| SCHEMBL30483734 | 0.84 | HTR1A (0.74) | HTR1AMPOHTR1DHTR2AHTR6 | |
| SCHEMBL4633747 | 0.84 | MPO (0.68) | HTR1AMPOHTR1DHTR2AHTR6 | |
| SCHEMBL25747532 | 0.84 | HTR1A (0.74) | HTR1AMPOHTR1DHTR2AHTR6 | |
| SCHEMBL30877289 | 0.84 | GPR84 (0.53) | HTR1AMPOHTR1DHTR2AHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023115166-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
| US-20080207728-A1 | BICYCLIC ACYLTRYPTOPHANOLS | BAYER SCHERING PHARMA AG (DE) | 2008-08-28 | — | — | US | disclosed |
| EP-1956016-A1 | Bicyclic acyltryptophanols | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-08-13 | — | — | EP | disclosed |
| WO-2008071455-A1 | BICYCLIC ACYLTRYPTOPHANOLS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-06-19 | — | — | WO | disclosed |
| EP-1912970-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-23 | — | — | EP | disclosed |
| US-20070060573-A1 | Acyltryptophanols | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | disclosed |
| WO-2007017289-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207728-A1 | BICYCLIC ACYLTRYPTOPHANOLS | FSHR, GNRHR, TPH1 | HTR1A 11/4885MPO 4034/4885HTR1D 14/4885 |
| US-20070060573-A1 | Acyltryptophanols | FSHR, NPY1R, NPY2R | HTR1A 8/4885MPO 4399/4885HTR1D 25/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.